{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:01:11Z","timestamp":1760299271227},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T00:00:00Z","timestamp":1450483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00380-015-0783-9","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T07:20:39Z","timestamp":1450509639000},"page":"1609-1615","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up"],"prefix":"10.1007","volume":"31","author":[{"given":"Hideki","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horinaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ishimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,19]]},"reference":[{"key":"783_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcin.2008.11.010","volume":"2","author":"B Horst","year":"2009","unstructured":"Horst B, Rihal CS, Holmes DR Jr, Bresnahan JF, Prasad A, Gau G, Lennon R, Lerman A (2009) Comparison of drug-eluting and bare-metal stents for stable coronary artery disease. JACC Cardiovasc Interv 2:321\u2013328","journal-title":"JACC Cardiovasc Interv"},{"key":"783_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","volume":"370","author":"C Stettler","year":"2007","unstructured":"Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Sch\u00f6mig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabat\u00e9 M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, J\u00fcni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis. Lancet 370:937\u2013948","journal-title":"Lancet"},{"key":"783_CR3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW Werkum van","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, Koolen JJ, Brueren BR, Dambrink JH, Hautvast RW, Verheugt FW, ten Berg JM (2009) Predictors of coronary stent thrombosis: the Dutch Stent thrombosis registry. J Am Coll Cardiol 53:1399\u20131409","journal-title":"J Am Coll Cardiol"},{"key":"783_CR4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.110.981688","volume":"123","author":"GD Dangas","year":"2011","unstructured":"Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, M\u00f6eckel M, Stone GW, Harmonizing Outcomes With Revascularization Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators (2011) Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123:1745\u20131756","journal-title":"Circulation"},{"issue":"19","key":"783_CR5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jacc.2010.08.608","volume":"56","author":"GW Stone","year":"2010","unstructured":"Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, M\u00f6ckel M, Lansky AJ, Mehran R (2010) Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 56(19):1597\u20131604","journal-title":"J Am Coll Cardiol"},{"key":"783_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jacc.2007.04.029","volume":"50","author":"M Valgimigli","year":"2007","unstructured":"Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, Barbieri D, Parrinello G, Percoco G, Ferrari R (2007) Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb\/IIIa inhibitor infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 50:138\u2013145","journal-title":"J Am Coll Cardiol"},{"key":"783_CR7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcin.2012.12.129","volume":"6","author":"L Holmvang","year":"2013","unstructured":"Holmvang L, Kelb\u00e6k H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kl\u00f8vgaard L, Engstr\u00f8m T, B\u00f8tker HE, Saunam\u00e4ki K, Krusell LR, J\u00f8rgensen E, Tilsted HH, Christiansen EH, Ravkilde J, K\u00f8ber L, Kofoed KF, Terkelsen CJ, Helqvist (2013) Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5\u00a0years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction). JACC Cardiovasc Interv. 6:548\u2013553","journal-title":"JACC Cardiovasc Interv."},{"key":"783_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/vhrm.2008.04.01.31","volume":"4","author":"I Sheiban","year":"2008","unstructured":"Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G (2008) Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V). Vasc Health Risk Manag 4:31\u201338","journal-title":"Vasc Health Risk Manag"},{"key":"783_CR9","first-page":"286","volume":"2","author":"PW Serruys","year":"2006","unstructured":"Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carri\u00e9 D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J (2006) A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial. EuroIntervention 2:286\u2013294","journal-title":"EuroIntervention"},{"key":"783_CR10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jcin.2011.06.018","volume":"4","author":"D Planer","year":"2011","unstructured":"Planer D, Smits PC, Kereiakes DJ, Kedhi E, Fahy M, Xu K, Serruys PW, Stone GW (2011) Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trials. JACC Cardiovasc Interv 4:1104\u20131115","journal-title":"JACC Cardiovasc Interv"},{"key":"783_CR11","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351","journal-title":"Circulation"},{"key":"783_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4244\/EIJV3I2A36","volume":"3","author":"MA Beijk","year":"2007","unstructured":"Beijk MA, Neumann FJ, Wiemer M, Grube E, Haase J, Thuesen L, Hamm C, Veldhof S, Dorange C, Serruys PW, Piek JJ (2007) Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). EuroIntervention 3:206\u2013212","journal-title":"EuroIntervention"},{"key":"783_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcin.2013.09.006","volume":"7","author":"M Sabat\u00e9","year":"2014","unstructured":"Sabat\u00e9 M, Brugaletta S, Cequier A, I\u00f1iguez A, Serra A, Hern\u00e1dez-Antol\u00edn R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, V\u00e1zquez N, Backx B, Serruys PW (2014) The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial. JACC Cardiovasc Interv 7:64\u201371","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 9","key":"783_CR14","first-page":"573","volume":"69","author":"Y Goto","year":"2011","unstructured":"Goto Y (2011) Guidelines for the management of patients with acute myocardial infarction (ST-elevation type). Nihon Rinsho 69(Suppl 9):573\u2013582","journal-title":"Nihon Rinsho"},{"issue":"4","key":"783_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcin.2008.11.015","volume":"2","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Iijima R, Mehilli J, Pinieck S, Bruskina O, Sch\u00f6mig A, Kastrati A (2009) Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. JACC Cardiovasc Interv 2(4):291\u2013299","journal-title":"JACC Cardiovasc Interv"},{"key":"783_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2010.03.031","volume":"106","author":"Y Nakagawa","year":"2010","unstructured":"Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K, j-Cypher Registry Investigators (2010) Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol 106:329\u2013336","journal-title":"Am J Cardiol"},{"key":"783_CR17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4244\/EIJV8I9A161","volume":"8","author":"Y Onuma","year":"2013","unstructured":"Onuma Y, Miquel-Hebert K, Serruys PW, Investigators SPIRITII (2013) Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial. EuroIntervention 8:1047\u20131051","journal-title":"EuroIntervention"},{"key":"783_CR18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","volume":"56","author":"DR Holmes Jr","year":"2010","unstructured":"Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ (2010) Stent thrombosis. J Am Coll Cardiol 56:1357\u20131365","journal-title":"J Am Coll Cardiol"},{"key":"783_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrcardio.2015.32","volume":"12","author":"DS Ong","year":"2015","unstructured":"Ong DS, Jang IK (2015) Causes, assessment, and treatment of stent thrombosis-intravascular imaging insights. Nat Rev Cardiol 12:325\u2013336","journal-title":"Nat Rev Cardiol"},{"key":"783_CR20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.108.844985","volume":"2","author":"B Lagerqvist","year":"2009","unstructured":"Lagerqvist B, Carlsson J, Fr\u00f6bert O, Lindb\u00e4ck J, Scherst\u00e9n F, Stenestrand U, James SK, Swedish Coronary Angiography and Angioplasty Registry Study Group (2009) Stent thrombosis in Sweden: a report from the Swedish coronary angiography and angioplasty registry. Circ Cardiovasc Interv 2:401\u2013408","journal-title":"Circ Cardiovasc Interv"},{"key":"783_CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/eurheartj\/ehn604","volume":"30","author":"PG Steg","year":"2009","unstructured":"Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum A, Huang W, Gore JM, Global Registry of Acute Coronary Events (GRACE) Investigators (2009) Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 30:321\u2013329","journal-title":"Eur Heart J"},{"key":"783_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.33398","author":"H Lan","year":"2015","unstructured":"Lan H, Wang Y, Yin T, Wang Y, Liu W, Zhang X, Yu Q, Wang Z, Wang G (2015) Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation. J Biomed Mater Res B Appl Biomater. doi: 10.1002\/jbm.b.33398","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"783_CR23","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","volume":"123","author":"K Kolandaivelu","year":"2011","unstructured":"Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, Coleman L, Wong GK, Edelman ER (2011) Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 123:1400\u20131409","journal-title":"Circulation"},{"key":"783_CR24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","volume":"379","author":"T Palmerini","year":"2012","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D\u2019Ascenzo F, Kimura T, Briguori C, Sabat\u00e8 M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379:1393\u20131402","journal-title":"Lancet"},{"key":"783_CR25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCINTERVENTIONS.114.001362","volume":"8","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Rutledge DR, Palmerini T, Caixeta A, Kedhi E, Hermiller JB, Wang J, Krucoff MW, Jones-McMeans J, Sudhir K, Simonton CA, Serruys PW, Stone GW (2015) Stent thrombosis and dual antiplatelet therapy interruption with everolimus-eluting stents: insights from the Xience V Coronary Stent System Trials. Circ Cardiovasc Interv 8:2","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-015-0783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-015-0783-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-015-0783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-015-0783-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:27:52Z","timestamp":1559057272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-015-0783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,19]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s00380-015-0783-9","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,19]]}}}